Glucagon biosimilar (Hospira)
胰高血糖素生物类似药 (Hospira)
Report date: 2022/07/04 19:38:02
Base Information
Drug NameGlucagon biosimilar (Hospira)
Drug Alias Name
Classification
Mechanisms of Action
Targets
Therapy Area/Indications
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/Territory
CombinationsNo
Global Highest StatusPending (Phase 1 Clinical)
Highest Status in ChinaN/A
Originator CompaniesHospira
China Registration ClassN/A
Develop Information
Other Information
ATC Code
Related LinksN/A